Covered recipient · General Payments record
RAJYA LAKSHMI ATLURI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$1,040.64
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $184.89 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $64.08 | 4 |
| Abbott Laboratories | $46.98 | 2 |
| PFIZER INC. | $17.08 | 1 |
| Novo Nordisk AS | $16.17 | 1 |
| INTRA-SANA LABORATORIES | $13.80 | 1 |
| Lilly USA, LLC | $13.50 | 1 |
| Acerta Pharma LLC | $13.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.28 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125314066 | CMS |
| Abbott Laboratories | $22.70 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125314068 | CMS |
| Amgen Inc. | $14.09 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117497710 | CMS |
| Amgen Inc. | $16.60 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117497712 | CMS |
| Amgen Inc. | $16.37 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117497714 | CMS |
| Amgen Inc. | $17.02 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117497716 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.28 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105862536 | CMS |
| Intra-Sana Laboratories | $13.80 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138616995 | CMS |
| Lilly USA, LLC | $13.50 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135326969 | CMS |
| Novo Nordisk Inc | $16.17 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096934191 | CMS |
| PFIZER INC. | $17.08 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131293615 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.